Healthcare Sector is Still Lagging- Can you Beat the S&P 500 with more Biotech?…. Update-1. biotechs!
Update-1 SMID biotechs rally underway as all there of our tracking ETFs are up ARKG up 5.6% , IBB, up 1.57%, XBI up 1.345 as a broad based rally pullls many stocks to new highs. Interest rate cut is "baked in". New small cap picks are all up: CBIO, PSNL, XNCR. Personalis (PSNL) big mover: new...
Small Cap Biopharmaceutical Stocks: Interim Update-3 Focus stocks: CBIO, PSNL, XNCR.
Small Cap Biopharma Stocks: Momentum Looks Good for Gains Our bellwether ETFs for this group are: Ark Genomic Revolution (ARKG) up 3% 1m and 5% YTD; S&P SPDR Biotech( XBI) up 7.66% 1m and 3.79% YTD. Most of these picks have been screened for analyst ratings (buy or above) and adequate cash...
Large Cap Biopharmaceuticals had a Good Month
Large Cap Biopharma Stocks Did Well in August Biopharma stocks offer growth plus dividends.Standouts are ABBV, AZN and GILD. Comeback candidates for 2026: from LLY,REGN and VRTX. Risk remains from tariffs and pushback from Trump Administration policies on drug pricing. Innovation is still key...
Focus on Small Cap Biotechs Now For A Q4 Rally…Update-1
8/28/25 UPDATE-1 A small cap rally has helped SMID biotechs stabilize to some degree with the IWM up 5.4% over one month and 7.04% YTD but the anticipated big rally in general small caps has not yet developed.For example the ARKG is seriously lagging down over 3% MTD but up 4.43% YTD mainly...
Biotech Momentum Rally Continues With Help from Healthcare in a Sector Rotation…Update-3…risk on!
Update-3 8/24 We will focus on Small cap biotechs from our trading list below over the next few weeks now that health care stocks have stabilized. If you have signed uo and are not getting our weekly updates please send an E mail to rod@rayno.com. Thank you. Update-2...11a Aug 22- Broad rally...